Skip to Main Content

Paper Details

Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants.
Nat Biotechnol
14
2022
-, ACE-2, SARS, SARS-CoV, SARS-CoV-2, angiotensin, angiotensin-converting enzyme 2, luciferase, receptor-binding domain, receptor-binding domain (RBD) construct, serum, severe acute respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 2
Author NameAffiliation
Alexandra C WallsUniversity of Washington
Laura A VanBlarganWashington University School of Medicine
John C KraftUniversity of Washington
John C KraftInstitute for Protein Design, University of Washington
Lauren CarterInstitute for Protein Design, University of Washington
David VeeslerUniversity of Washington
David VeeslerHoward Hughes Medical Institute, University of Washington
Michael S DiamondWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondAndrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine
Alexander L GreningerUniversity of Washington
Alexander L GreningerFred Hutchinson Cancer Research Center
David BakerUniversity of Washington
David BakerInstitute for Protein Design, University of Washington
David BakerHoward Hughes Medical Institute, University of Washington
David BakerUniversity of Washington
David BakerInstitute for Protein Design, University of Washington
David BakerHoward Hughes Medical Institute, University of Washington
  • 1 - 19

Datasets

Release 1.2